1 September 2017 EMA/524592/2017 Human Medicines Evaluation Division

List of nationally authorised medicinal products

Active substance: lidocaine hydrochloride / phenylephrine hydrochloride / tropicamide

Procedure no.: PSUSA/00010390/201701

30 Churchill Place ● Canary Wharf ● London E14 5EU ● United Kingdom Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 5525 Send a question via our website www.ema.europa.eu/contact

An agency of the European Union

© European Medicines Agency, 2017. Reproduction is authorised provided the source is acknowledged.

Product Name (in authorisation country)

MRP/DCP Authorisation number

National Authorisation Number

MAH of product in the member state

Member State where product is authorised

Mydane 0,2 mg/ml + 3,1

DK/H/2439/001

14/10062

LABORATOIRES THEA

NO

DK/H/2439/001

HR-H-561244487

LABORATOIRES THEA

HR

DK/H/2439/001

5659370

LABORATOIRES THEA

PT

DK/H/2439/001

5659404

LABORATOIRES THEA

PT

DK/H/2439/001

PL 20162/0022

LABORATOIRES THEA

UK

DK/H/2439/001

64/399/15-C

LABORATOIRES THEA

CZ

DK/H/2439/001

54107

LABORATOIRES THEA

DK

DK/H/2439/001

IS/1/15/093/01

LABORATOIRES THEA

IS

DK/H/2439/001

64/0323/15-S

LABORATOIRES THEA

SK

mg/ml + 10 mg/ml injeksjonsvæske, oppløsning MYDRANE 0,2 mg/ml + 3,1 mg/ml + 10 mg/ml otopina za injekciju MYDRANE 0,2 mg/ml + 3,1 mg/ml + 10 mg/ml solução injetável MYDRANE 0,2 mg/ml + 3,1 mg/ml + 10 mg/ml solução injetável Mydrane 0.2 mg/ml + 3.1 mg/ml + 10 mg/ml solution for injection. Mydrane 0,2 mg/ml + 3,1 mg/ml + 10 mg/ml injekční roztok Mydrane, injektionsvæske, opløsning MYDRANE 0,2 mg/ml + 3,1 mg/ml + 10 mg/ml stungulyf, lausn MYDRANE 0,2 mg/ml + 3,1 mg/ml + 10 mg/ml injekčný roztok

List of nationally authorised medicinal products EMA/524592/2017

Page 2/5

Product Name (in authorisation country)

MRP/DCP Authorisation number

National Authorisation Number

MAH of product in the member state

Member State where product is authorised

Fydrane 0.2 mg/ml + 3.1

DK/H/2439/001

PA 1107/012/001

LABORATOIRES THEA

IE

DK/H/2439/001

043455043

LABORATOIRES THEA

IT

DK/H/2439/001

043455056

LABORATOIRES THEA

IT

DK/H/2439/001

043455068

LABORATOIRES THEA

IT

DK/H/2439/001

8107/2015/01-03

LABORATOIRES THEA

RO

DK/H/2439/001

92056.00.00

LABORATOIRES THEA

DE

DK/H/2439/001

136615

LABORATOIRES THEA

AT

DK/H/2439/001

22899

LABORATOIRES THEA

PL

DK/H/2439/001

20150368

LABORATOIRES THEA

BG

mg/ml + 10 mg/ml solution for injection MYDRANE, 0,2 mg/ml + 3,1 mg/ml + 10 mg/ml, soluzione iniettabile MYDRANE, 0,2 mg/ml + 3,1 mg/ml + 10 mg/ml, soluzione iniettabile MYDRANE, 0,2 mg/ml + 3,1 mg/ml + 10 mg/ml, soluzione iniettabile MYDRANE 0,2 mg/ml + 3,1 mg/ml + 10 mg/ml soluție injectabilă. Mydrane, 0,2 mg/ml+ 3,1 mg/ml+ 10 mg/ml, Injektionslösung Mydrane 0,2 mg/ml + 3,1 mg/ml + 10 mg/ml Injektionslösung Mydrane, (0,2 mg + 3,1 mg + 10 mg)/ml, roztwór do wstrzykiwań МИДРАН 0,2 mg/ml + 3,1 mg/ml + 10 mg/ml инжекционен разтвор.

List of nationally authorised medicinal products EMA/524592/2017

Page 3/5

Product Name (in authorisation country)

MRP/DCP Authorisation number

National Authorisation Number

MAH of product in the member state

Member State where product is authorised

FYDRANE, 0,2 mg/ml +

DK/H/2439/001

80177

LABORATOIRES THEA

ES

DK/H/2439/001

34009 550 153 8 3

LABORATOIRES THEA

FR

DK/H/2439/001

34009 550 153 9 0

LABORATOIRES THEA

FR

DK/H/2439/001

34009 550 154 1 3

LABORATOIRES THEA

FR

DK/H/2439/001

RVG 115295

LABORATOIRES THEA

NL

DK/H/2439/001

BE489680

LABORATOIRES THEA

BE

DK/H/2439/001

BE489680

LABORATOIRES THEA

BE

DK/H/2439/001

51088

LABORATOIRES THEA

SE

DK/H/2439/001

32232

LABORATOIRES THEA

FI

3,1 mg/ml + 10 mg/ml, solución inyectable MYDRANE 0,2 mg/ml + 3,1 mg/ml + 10 mg/ml, solution injectable MYDRANE 0,2 mg/ml + 3,1 mg/ml + 10 mg/ml, solution injectable MYDRANE 0,2 mg/ml + 3,1 mg/ml + 10 mg/ml, solution injectable MYDRANE 0,2 mg/ml + 3,1 mg/ml + 10 mg/ml oplossing voor injectie Mydrane 0,2 mg/ml + 3,1 mg/ml + 10 mg/ml oplossing voor injectie Mydrane 0,2 mg/ml + 3,1 mg/ml + 10 mg/ml solution injectable Mydrane 0,2 mg/ml + 3,1 mg/ml + 10 mg/ml injektionsvätska, lösning MYDRANE 0,2 mg/ml + 3,1 mg/ml + 10 mg/ml injektioneste, liuos

List of nationally authorised medicinal products EMA/524592/2017

Page 4/5

Product Name (in authorisation country)

MRP/DCP Authorisation number

National Authorisation Number

MAH of product in the member state

Member State where product is authorised

Mydrane 0,2 mg/ml + 3,1

DK/H/2439/001

51088

LABORATOIRES THEA

SE

DK/H/2439/001

36484/27-4-2016

LABORATOIRES THEA

GR

DK/H/2439/001

2016110311

LABORATOIRES THEA

LU

DK/H/2439/001

H/17/02267/001-003

LABORATOIRES THEA

SI

mg/ml + 10 mg/ml injektionsvätska, lösning MYDRANE 0,2 mg/ml + 3,1 mg/ml + 10 mg/ml ενέσιμο διάλυμα. Mydrane 0,2 mg/ml + 3,1 mg/ml + 10 mg/ml solution injectable Mydrane 0,2 mg/ml + 3,1 mg/ml + 10 mg/ml raztopina za injiciranje

List of nationally authorised medicinal products EMA/524592/2017

Page 5/5

Lidocaine hydrochloride / phenylephrine hydrochloride / tropicamide ...

Sep 1, 2017 - Send a question via our website www.ema.europa.eu/contact. © European Medicines Agency ... Product Name (in authorisation country). MRP/ ...

108KB Sizes 0 Downloads 116 Views

Recommend Documents

lidocaine hydrochloride / phenylephrine hydrochloride / tropicamide ...
Mar 8, 2018 - Member State where product is authorised. Mydane 0,2 mg/ml + 3,1 mg/ml + 10 mg/ml injeksjonsvæske, oppløsning. DK/H/2439/001. 14/10062.

Active substance: lidocaine hydrochloride / phenylephrine ...
Sep 2, 2016 - Fydrane 0.2 mg/ml + 3.1 mg/ml + 10 mg/ml solution for injection. DK/H/2439/001. PA 1107/012/001. LABORATOIRES THEA. IE. FYDRANE, 0,2 ...

amitriptyline hydrochloride / chlordiazepoxide - European Medicines ...
Sep 29, 2016 - Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 5555. Send a question via our website www.ema.europa.eu/contact. © European ...

amitriptyline hydrochloride / chlordiazepoxide: List of nationally ...
Sep 28, 2017 - List of nationally authorised medicinal products. Active substance: amitriptyline ... Member State where product is authorised. Limbitrol 12,5 ...

Tasermity, INN-sevelamer hydrochloride - European Medicines Agency
Feb 26, 2018 - The cessation of validity is due to the fact that the marketing authorisation holder, Genzyme Europe BV, had not marketed Tasermity in the EU since its initial marketing authorisation. In accordance with provisions of the sunset clause

Clinical Efficacy of Olopatadine Hydrochloride ... - ScienceDirect.com
David T. Wells, RN, BSN,4 Michael VW. Bergamini, PhD,4 and Stella M. Robertson, PhD4. lSchepens Eye Research Institute, Boston, 2Harvard Medical School, ...

bendamustine hydrochloride: CMDh scientific conclusions and ...
Oct 29, 2016 - PRAC reviewed the available post marketing safety data, published ... The CMDh reaches the position that the marketing authorisation(s) of ...

caffeine / drotaverine hydrochloride / metamizol sodium - European ...
Jul 12, 2018 - Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 5525. Send a question via our ... number. National Authorisation Number. MAH of product in the member state ... 73/0633/92-S. SANOFI-AVENTIS SLOVAKIA. SRO.

and Aniline Hydrochloride - European Medicines Agency - Europa EU
Aug 25, 2015 - database and literature searches for carcinogenicity and bacterial ...... http://ntp.niehs.nih.gov/ntp/roc/twelfth/profiles/bis(chloromethyl)ether.pdf.

3-methyl Methcathinone Hydrochloride Wholesale - +31 207 601 ...
... benzofuran, substituted amphetamine and substituted phenethylamine classes. ... 3-methyl Methcathinone Hydrochloride Wholesale - +31 207 601 080.pdf.

GamlinPDR-1989-Lidocaine-induced-INO.pdf
Effects on Convergence and Conjugate Eye Movements .... this example, there is a blockade of the left MLF, and the. viewing ... BEAM CHOPPER I ... METHODS.

Lidocaine / prilocaine - European Medicines Agency - Europa EU
Nov 30, 2017 - Member State where product is authorised. LIDOCAINE / PRILOCAINE ZENTIVA 5. % PANSEMENT ADHESIF CUTANE not available. 34009 276 655 1 6. SANOFI-AVENTIS FRANCE. FR. EMLA, 25 mg/g + 25 mg/g, creme. UK/H/6112/001. 2443588. ASTRAZENECA PRO